Search research articles
Contact Us
Filters
Showing results (41-50 of 77) with videos related to
Page
of 8
Sort By:
Bone
|
March 26, 2019
High frequency of paternal iso or heterodisomy at chromosome 20 associated with sporadic pseudohypoparathyroidism 1B
Cindy Colson, Matthieu Decamp, Nicolas Gruchy, et al.
Inflammatory Bowel Diseases
|
June 25, 2025
Long-Term Outcome of Colonic and Ileal Crohn's Disease: A Two-Decade Population-Based Study in Pediatric-Onset Disease
Mathurin Fumery, Guillaume Savoye, Hélène Sarter, et al.
Journal of Clinical Medicine
|
September 16, 2020
The Wide Spectrum of COVID-19 Clinical Presentation in Children
Nadia Nathan, Blandine Prevost, Chiara Sileo, et al.
The Lancet Regional Health. Europe
|
October 31, 2024
Incidence, prevalence and clinical presentation of inflammatory bowel diseases in Northern France: a 30-year population-based study
Hélène Sarter, Thibaut Crétin, Guillaume Savoye, et al.
Rheumatology (Oxford, England)
|
December 26, 2016
Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues
Nicolas Richard, Marie Hudson, Geneviève Gyger, et al.
United European Gastroenterology Journal
|
December 8, 2025
TNF Inhibitor-Induced Sarcoidosis-Like Lesions in Inflammatory Bowel Disease
Zlata Chkolnaia, Benedicte Lebrun-Vignes, Aurelien Amiot, et al.
Frontiers in Endocrinology
|
November 1, 2021
Overlapping Phenotypes Associated With <i>CYP24A1</i>, <i>SLC34A1</i>, and <i>SLC34A3</i> Mutations: A Cohort Study of Patients With Hypersensitivity to Vitamin D
Arnaud Molin, Sandrine Lemoine, Martin Kaufmann, et al.
Clinical Lung Cancer
|
January 26, 2019
Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2)
Michèle Beau-Faller, Matthieu Texier, Hélène Blons, et al.
Alimentary Pharmacology & Therapeutics
|
April 27, 2026
One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID Study
Nicolas Richard, Philippe Seksik, Romain Altwegg, et al.
Clinical Lung Cancer
|
June 1, 2019
Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice
Philippe Jamme, Clotilde Descarpentries, Radj Gervais, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 77) with videos related to
Sort By:
Page
of 8
Bone
|
March 26, 2019
High frequency of paternal iso or heterodisomy at chromosome 20 associated with sporadic pseudohypoparathyroidism 1B
Cindy Colson, Matthieu Decamp, Nicolas Gruchy, et al.
Inflammatory Bowel Diseases
|
June 25, 2025
Long-Term Outcome of Colonic and Ileal Crohn's Disease: A Two-Decade Population-Based Study in Pediatric-Onset Disease
Mathurin Fumery, Guillaume Savoye, Hélène Sarter, et al.
Journal of Clinical Medicine
|
September 16, 2020
The Wide Spectrum of COVID-19 Clinical Presentation in Children
Nadia Nathan, Blandine Prevost, Chiara Sileo, et al.
The Lancet Regional Health. Europe
|
October 31, 2024
Incidence, prevalence and clinical presentation of inflammatory bowel diseases in Northern France: a 30-year population-based study
Hélène Sarter, Thibaut Crétin, Guillaume Savoye, et al.
Rheumatology (Oxford, England)
|
December 26, 2016
Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues
Nicolas Richard, Marie Hudson, Geneviève Gyger, et al.
United European Gastroenterology Journal
|
December 8, 2025
TNF Inhibitor-Induced Sarcoidosis-Like Lesions in Inflammatory Bowel Disease
Zlata Chkolnaia, Benedicte Lebrun-Vignes, Aurelien Amiot, et al.
Frontiers in Endocrinology
|
November 1, 2021
Overlapping Phenotypes Associated With <i>CYP24A1</i>, <i>SLC34A1</i>, and <i>SLC34A3</i> Mutations: A Cohort Study of Patients With Hypersensitivity to Vitamin D
Arnaud Molin, Sandrine Lemoine, Martin Kaufmann, et al.
Clinical Lung Cancer
|
January 26, 2019
Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2)
Michèle Beau-Faller, Matthieu Texier, Hélène Blons, et al.
Alimentary Pharmacology & Therapeutics
|
April 27, 2026
One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID Study
Nicolas Richard, Philippe Seksik, Romain Altwegg, et al.
Clinical Lung Cancer
|
June 1, 2019
Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice
Philippe Jamme, Clotilde Descarpentries, Radj Gervais, et al.
Page
of 8